Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Walsh

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
Plos Biology|January 1, 2019
Enabling precision medicine via standard communication of HTS provenance, analysis, and resultsGil Alterovitz, Dennis Dean, Carole Goble, et al.
Journal of Medicinal Chemistry|March 22, 2017
Can We Make Small Molecules Lean? Optimization of a Highly Lipophilic TarO InhibitorMihirbaran Mandal, Zheng Tan, Christina Madsen-Duggan, et al.
Journal of Medicinal Chemistry|March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D Scott, Duane E DeMong, Thomas J Greshock, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
Plos Biology|January 1, 2019
Enabling precision medicine via standard communication of HTS provenance, analysis, and resultsGil Alterovitz, Dennis Dean, Carole Goble, et al.
Journal of Medicinal Chemistry|March 22, 2017
Can We Make Small Molecules Lean? Optimization of a Highly Lipophilic TarO InhibitorMihirbaran Mandal, Zheng Tan, Christina Madsen-Duggan, et al.
Journal of Medicinal Chemistry|March 1, 2017
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D Scott, Duane E DeMong, Thomas J Greshock, et al.
Pageof 8